Colossal Laboratories & Bioscience is a pioneering bioscience company dedicated to de-extinction. By integrating advanced genetic science and innovative technology, Colossal aims to resurrect extinct species. The company’s mission focuses on enhancing biodiversity, restoring ecological balance, and advancing genetic research to create a sustainable future through ecological and genetic restoration efforts.
Founded: 2021
The dire wolves are moving together as a pack and beginning to hunt. Here’s what we learned during our visit and what's coming next.
Colossal Biosciences announced late Monday it had received a $60 million investment from the United Arab Emirates, and the first location of its planned BioVault conservation initiative.
This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris Hilton and Barbra Streisand.
Here are the 300 best inventions making the world better, smarter, and more fun.
Colossal Biosciences, the world’s de-extinction company, today announces several milestones in avian cellular science, bringing the dodo revival one step closer. The Colossal Avian Genetics Group has successfully grown pigeon primordial germ cells (PGCs) for the first time in history, a pivotal step in bringing back the dodo. In addition to this breakthrough, Colossal has also announced an additional expansion of $120M in new funding.